Increased susceptibility to septic and endotoxic shock in monocyte chemoattractant protein 1/CC chemokine ligand 2-deficient mice correlates with reduced interleukin 10 and enhanced macrophage migration inhibitory factor production

被引:52
作者
Gomes, Rachel N.
Figueiredo, Rodrigo T.
Bozza, Fernando A.
Pacheco, Patricia
Amancio, Rodrigo T.
Laranjeira, Andrea P.
Castro-Faria-Neto, Hugo C.
Bozza, Patricia T.
Bozza, Marcelo T.
机构
[1] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Imunol, Lab Inflamacao & Imunidade, BR-21941590 Rio De Janeiro, Brazil
[2] Fundacao Oswaldo Cruz, IOC, Dept Fisiol & Farmacodinam, Lab Imunofarmacol, BR-21045900 Rio De Janeiro, Brazil
[3] Fundacao Oswaldo Cruz, LATEB, BR-21045900 Rio De Janeiro, Brazil
[4] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Ctr Tratamento Intens, BR-21045900 Rio De Janeiro, Brazil
来源
SHOCK | 2006年 / 26卷 / 05期
关键词
MCP-1; CCL2; CLP; endotoxin; sepsis; cytokines;
D O I
10.1097/01.shk.0000228801.56223.92
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
The chemokine monocyte chemoattractant protein 1/CC chemokine ligand 2 (MCP-1/CCL2) is a potent chemoattractant of mononuclear cells and a regulatory mediator involved in a variety of inflammatory diseases. In the present study, we demonstrate that mcp-1/ccl2-deficient mice are more susceptible to systemic inflammatory response syndrome induced by lipopolysaccharide and to polymicrobial sepsis induced by cecum ligation and puncture (CLP) when compared with wild-type mice. Interestingly, in the CLP model, mcp-1/ccl2 deficient mice efficiently cleared the bacteria despite an impaired recruitment of leukocytes, especially mononuclear cells. The increased lethality rate in these models correlates with an impaired production of interleukin (IL) 10 in vivo. Furthermore, macrophages from mcp-1/ccl2-deficient mice activated with lipopolysaccharide also produced lower amounts of IL-10 and similar tumor necrosis factor compared with wild-type mice. We observed a drastic increase in the amounts of macrophage migration inhibitory factor at 6 and 24 h after CLP in mcp-1/ccl2-deficient mice. These results indicate that endogenous MCP-1/CCL2 positively regulates IL-10 but negatively controls macrophage migration inhibitory factor during peritoneal sepsis, thus suggesting an important immunomodulatory role for MCP-1/CCL2 in controlling the balance between proinflammatory and anti-inflammatory factors in sepsis.
引用
收藏
页码:457 / 463
页数:7
相关论文
共 39 条
[1]
Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia [J].
Amano, H ;
Morimoto, K ;
Senba, M ;
Wang, H ;
Ishida, Y ;
Kumatori, A ;
Yoshimine, H ;
Oishi, K ;
Mukaida, N ;
Nagatake, T .
JOURNAL OF IMMUNOLOGY, 2004, 172 (01) :398-409
[2]
INTERLEUKIN-10 IS A CENTRAL REGULATOR OF THE RESPONSE TO LPS IN MURINE MODELS OF ENDOTOXIC-SHOCK AND THE SHWARTZMAN REACTION BUT NOT ENDOTOXIN TOLERANCE [J].
BERG, DJ ;
KUHN, R ;
RAJEWSKY, K ;
MULLER, W ;
MENON, S ;
DAVIDSON, N ;
GRUNIG, G ;
RENNICK, D .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2339-2347
[3]
MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[4]
PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[5]
PLASMA-LEVELS OF THE CHEMOKINES MONOCYTE CHEMOTACTIC PROTEIN-1 AND PROTEIN-2 ARE ELEVATED IN HUMAN SEPSIS [J].
BOSSINK, AWJ ;
PAEMEN, L ;
JANSEN, PM ;
HACK, CE ;
THIJS, LG ;
VANDAMME, J .
BLOOD, 1995, 86 (10) :3841-3847
[6]
Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis [J].
Bozza, FA ;
Gomes, RN ;
Japiassú, AM ;
Soares, M ;
Castro-Faria-Neto, HC ;
Bozza, PT ;
Bozza, MT .
SHOCK, 2004, 22 (04) :309-313
[7]
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis [J].
Bozza, M ;
Satoskar, AR ;
Lin, GS ;
Lu, B ;
Humbles, AA ;
Gerard, C ;
David, JR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :341-346
[8]
Protection from septic shock by neutralization of macrophage migration inhibitory factor [J].
Calandra, T ;
Echtenacher, B ;
Le Roy, D ;
Pugin, J ;
Metz, CN ;
Hültner, L ;
Heumann, D ;
Männel, D ;
Bucala, R ;
Glauser, MP .
NATURE MEDICINE, 2000, 6 (02) :164-170
[9]
Chensue SW, 1996, J IMMUNOL, V157, P4602
[10]
Critical protective role of mast cells in a model of acute septic peritonitis [J].
Echtenacher, B ;
Mannel, DN ;
Hultner, L .
NATURE, 1996, 381 (6577) :75-77